Mutations in HDAC enzymes are associated with tumor development, likely due to the resulting dysregulation of pathways involved in cell proliferation, cell cycle regulation and apoptosis and changes in the transcriptional status of oncogenes and tumor suppressors[179]. The gene discussed is HDAC9; the disease is neoplasm.